Meeting
2022 ASCO Annual Meeting
A pilot study to increase cascade genetic testing in families with hereditary cancer syndromes.
Authors
Steven J. Katz
University of Michigan, Ann Arbor, MI
Steven J. Katz , Rachel Tocco , Sarah T. Hawley , Lawrence An , Rachel Hodan , Kevin C Ward , Allison W. Kurian
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Hereditary Cancer Syndromes
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 10602)
DOI
10.1200/JCO.2022.40.16_suppl.10602
Abstract #
10602
Poster Bd #
477
Abstract Disclosures
Similar Posters
First Author: Krystal Brown
Poster
2023 ASCO Annual Meeting
Comprehensive analysis of patients with cancer with a positive CHEK2 test: Are we getting closer to a genotype/phenotype correlation?
First Author: Ana Fragoso
Poster
2023 ASCO Annual Meeting
Women with pathogenic variants in moderate penetrance breast cancer genes: How frequently do they meet high penetrance genetic testing criteria?
First Author: Nicole Casasanta
Poster
2020 ASCO Virtual Scientific Program
Development and validation of the PREMMplus clinical prediction model for multigene hereditary cancer risk assessment.
First Author: Matthew B. Yurgelun